Campylobacter jejuni infection and Guillain–Barré syndrome JH Rees, SE Soudain, NA Gregson, RAC Hughes New England Journal of Medicine 333 (21), 1374-1379, 1995 | 1042 | 1995 |
Clinical and epidemiologic features of Guillain-Barré syndrome RAC Hughes, JH Rees Journal of Infectious Diseases 176 (Supplement_2), S92-S98, 1997 | 691 | 1997 |
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force R Soffietti, BG Baumert, L Bello, A Von Deimling, H Duffau, M Frénay, ... European journal of neurology 17 (9), 1124-1133, 2010 | 591 | 2010 |
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study BG Baumert, ME Hegi, MJ van den Bent, A von Deimling, T Gorlia, ... The Lancet Oncology 17 (11), 1521-1532, 2016 | 530 | 2016 |
Epidemiological study of Guillain-Barré syndrome in south east England JH Rees, RD Thompson, NC Smeeton, RAC Hughes Journal of Neurology, Neurosurgery & Psychiatry 64 (1), 74-77, 1998 | 357 | 1998 |
Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infection JH Rees, NA Gregson, RAC Hughes Annals of Neurology: Official Journal of the American Neurological …, 1995 | 357 | 1995 |
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the … PJ Hayden, C Roddie, P Bader, GW Basak, H Bonig, C Bonini, ... Annals of oncology 33 (3), 259-275, 2022 | 312 | 2022 |
Low-Grade Gliomas: Do Changes in rCBV Measurements at Longitudinal Perfusion-weighted MR Imaging Predict Malignant Transformation?1 N Danchaivijitr, AD Waldman, DJ Tozer, CE Benton, G Brasil Caseiras, ... Radiology 247 (1), 170-178, 2008 | 271 | 2008 |
Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature L Spain, G Walls, M Julve, K O’Meara, T Schmid, E Kalaitzaki, S Turajlic, ... Annals of Oncology 28 (2), 377-385, 2017 | 269 | 2017 |
The role of [18F] fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders JH Rees, SF Hain, MR Johnson, RAC Hughes, DC Costa, PJ Ell, G Keir, ... Brain 124 (11), 2223-2231, 2001 | 187 | 2001 |
Apparent diffusion coefficient histograms may predict low‐grade glioma subtype DJ Tozer, HR Jäger, N Danchaivijitr, CE Benton, PS Tofts, JH Rees, ... NMR in Biomedicine: An International Journal Devoted to the Development and …, 2007 | 184 | 2007 |
A follow up study of patients with paraneoplastic neurological disease in the United Kingdom PM Candler, PE Hart, M Barnett, R Weil, JH Rees Journal of Neurology, Neurosurgery & Psychiatry 75 (10), 1411-1415, 2004 | 175 | 2004 |
Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation J Rees, H Watt, HR Jäger, C Benton, D Tozer, P Tofts, A Waldman European journal of radiology 72 (1), 54-64, 2009 | 162 | 2009 |
Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage JH Rees Journal of Neurology, Neurosurgery & Psychiatry 75 (suppl 2), ii43-ii50, 2004 | 160 | 2004 |
Advances in magnetic resonance imaging of brain tumours J Rees Current opinion in neurology 16 (6), 643-650, 2003 | 155 | 2003 |
Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. CP O'Leary, J Veitch, WF Durward, AM Thomas, JH Rees, HJ Willison Journal of Neurology, Neurosurgery & Psychiatry 61 (6), 649-651, 1996 | 148 | 1996 |
MRI of the brain with ultra-short echo-time pulse sequences A Waldman, JH Rees, CS Brock, MD Robson, PD Gatehouse, GM Bydder Neuroradiology 45, 887-892, 2003 | 138 | 2003 |
Quantitative imaging biomarkers in neuro-oncology AD Waldman, A Jackson, SJ Price, CA Clark, TC Booth, DP Auer, PS Tofts, ... Nature Reviews Clinical Oncology 6 (8), 445-454, 2009 | 131 | 2009 |
Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment G Singh, JH Rees, JW Sander Journal of Neurology, Neurosurgery & Psychiatry 78 (4), 342-349, 2007 | 126 | 2007 |
HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection JH Rees, RW Vaughan, E Kondeatis, RAC Hughes Journal of neuroimmunology 62 (1), 53-57, 1995 | 125 | 1995 |